Evaluation of efficacy and safety of autologous bone marrow mesenchymal stem cells for traumatic spinal cord injury: Use-results comparative survey
Not Applicable
Recruiting
- Conditions
- Spinal Cord Injury
- Registration Number
- JPRN-jRCT2053210130
- Lead Sponsor
- Room Stemirac Information
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 612
Inclusion Criteria
(1) Patients using autologous mesenchymal stem cells derived from bone marrow for the first time for traumatic spinal cord injury
(2) Patients or their surrogates must provide informed consent before the start
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method